24 O T T O B R E • S A L A A L C M E O N E P A D COMUNICAZIONI ORALI: DISORDINI DEL MOVIMENTO 1 ore 11.30 - 13.30 Moderatori P. BARONE (Napoli) - B.N. MERCURI (Roma) 11.30 CLINICAL AND DAT-SPECT FOLLOW-UP STUDY OF PATIENTS WITH MIXED TREMORS AND PRESERVED NIGROSTRIATAL SYSTEM G. ARABIA, F. NOVELLINO, A. BAGNATO, G. CASCINI, M. MORELLI, M. SALSONE, L. GIOFRÈ, G. NICOLETTI, D. MESSINA, A. QUATTRONE (Germaneto - CZ, Cosenza, Piano Lago <strong>di</strong> Mangone - CS) 11.45 ABNORMAL SYNAPTIC PLASTICITY IN PRIMARY MOTOR CORTEX IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY D. BELVISI, A. CONTE, M. BOLOGNA, D. OTTAVIANI, A. SUPPA, G. FABBRINI, C. COLOSIMO, D. WILLIAMS, A. BERARDELLI (Roma, Venafro - IS, Melbourne - AUS) 12.00 GAK/DGKQ GENE VARIANTS AND SPORADIC PARKINSON’S DISEASE: A CASE-CONTROL STUDY L. BRIGHINA, C. RIVA, S. FERMI, E. SARACCHI, F. BERTOLA, S. GOLDWURM, G. PEZZOLI, C. FERRARESE (Monza, Milano, Bosisio Parini - MI) 12.15 ASSOCIATION OF MILD COGNITIVE IMPAIRMENT SUBTYPES WITH PARKINSON’S DISEASE C. CAMARDA, R. MONASTERO, G. VENTIMIGLIA, C. VENTIMIGLIA, A. FALSONE, P. DI FIORE, C. CORRENTE, I. BATTAGLINI, R. CAMARDA (Palermo) 12.30 PERSONALITY DISORDER IS A HIGHLY FREQUENT NON-MOTOR SYMPTOM IN EARLY PARKINSON DISEASE A. NICOLETTI, A. LUCA, L. RACITI, E. BRUNO, P. FUDA, A. PETRALIA, D. CONTRAFATTO, S. LANZAFAME, G. MOSTILE, G. SCIACCA, G. DONZUSO, M. ZAPPIA (Catania) 12.45 STATUS DYSTONICUS: PREDICTORS OF OUTCOME AND PROGRESSION PATTERNS OF UNDERLYING DISEASE A. FASANO, L. RICCIARDI, A. BENTIVOGLIO, C. CANAVESE, G. ZORZI, I. PETROVIC, N. KRESOJEVIS, N. KOVACS, A. ROUBERTIE, D. MISHRA, P. MARIOTTI, N. NARDOCCI (Roma, Messina, Milano, Belgrade - SRB, Pecs - H, Montpellier - F, Delhi - IND) 13.00 THE TOPOGRAPHICAL DISTRIBUTION OF WHITE MATTER DAMAGE IN PARKINSON’S DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY M. FILIPPI, F. AGOSTA, M. PIEVANI, S. GALANTUCCI, T. STOJKOVI, A. TOMI, I. PETROVI, G. COMI, V. KOSTIC (Milano, Belgrado - SRB) 13.15 CORTICAL STIMULATION IN FOCAL AND SEGMENTAL DYSTONIA S. LALLI, S. PIACENTINI, A. FRANZINI, G. MESSINA, F. FERRÈ, D. PERANI, A. ALBANESE (Milano) F 13.30 - 14.30 <strong>Pausa</strong> <strong>pranzo</strong> 22
COMUNICAZIONI ORALI: MALATTIE CEREBROVASCOLARI 1 ore 11.30 - 13.30 Moderatori D. CONSOLI (Vibo Valentia) - M. PRENCIPE (Roma) 11.30 ABCD2 SCORE VALIDATION IN ITALY. TIA INCIDENCE AND 2-, 7-, 30- AND 90-DAY STROKE RISK F. JANES, I. CANCELLI, M. VALENTE, A. PERELLI, L. D'ANNA, G. CANAL, B. ZANCHETTIN, G. GIGLI (U<strong>di</strong>ne) 11.45 DIET AND QUALITY OF LIFE IN THE AEOLIAN ISLANDS P. L A SPINA, R. SAVICA, M. CASELLA, M. COTRONEO, A. ANASTASI, G. DRAGO FERRANTE, F. GRILLO, C. DELL'AERA, S. SERRA, U. MURACA, R. MUSOLINO (Messina) 12.00 BASELINE TOTAL CHOLESTEROL LEVELS AND RISK OF SYMPTOMATIC HEMORRHAGIC TRANSFORMATION AFTER INTRAVENOUS THROMBOLSYIS IN ACUTE ISCHEMIC STROKE PATIENTS S. LORENZANO, E. PUCA, N. AHMED, S. SPOLVERI, G. AGNELLI, L. BETTONI, C. SERRATI, E. LUDA, V. DI LAZZARO, A. VINATTIERI, N. WAHLGREN, M. PRENCIPE, D. TONI (Roma, Boston - USA, Stockolm - S, Firenze, Perugia, Cremona, Genova, Rivoli - TO, Prato) 12.15 INTRACRANIAL ARTERY STENOSIS REGISTRY: ANALYSIS OF 101 CONSECUTIVE PATIENTS WITH FIRST EPISODE OF CEREBROVASCULAR DISEASE L. MALFATTO, L. ALLEGRETTI, A. SENEGHINI, D. RIZZI, N. MAVILIO, M. SIRI, P. MOSCATELLI, M. MORFINO, C. SERRATI, G. REGESTA, G.A. OTTONELLO, L. CASTELLAN (Genova, Imperia) 12.30 RISK OF RECURRENT CEREBROVASCULAR EVENTS IN PATIENTS WITH CRYPTOGENIC STROKE OR TRANSIENT ISCHEMIC ATTACK AND PATENT FORAMEN OVALE. THE FORI (FORAMEN OVALE REGISTRO ITALIANO) STUDY M. PACIARONI, G. AGNELLI, A. BERTOLINI, A. PEZZINI, A. PADOVANI, V. CASO, M. VENTI, A. ALBERTI, R. PALMIERO, P. CERRATO, G. SILVESTRELLI, A. LANARI, P. PREVIDI, F. COREA, A. BALDUCCI, R. FERRI, F. FALCINELLI, E. FILIPPUCCI, P. CHIOCCHI, F. CHIODO GRANDI, L. FERIGO, R. MUSOLINO, A. BERSANO, I. GHIONE, S. SACCO, A. CAROLEI, A. BALDI, W. AGENO (Perugia, Varese, Brescia, Torino, Mantova, Foligno - PG, Trieste, Messina, Milano, L’Aquila, Portogruaro - VE) 12.45 OUTCOME OF PATIENTS WITH ACUTE CEREBRAL ISCHEMIC EVENTS AND REVERSED ROBIN HOOD SYNDROME P. PALAZZO, C. BALUCANI, F. VERNIERI, G. TSIVGOULIS, C. ALTAMURA, P. MAGGIO, P. M. ROSSINI, A. V. ALEXANDROV (Roma, Birmigham - USA) 13.00 RISK OF FUNCTIONAL DECLINE BY GRADE OF AGE-RELATED WHITE MATTER CHANGES: SIXTH YEAR FOLLOW-UP OF THE LADIS (LEUKOARAIOSIS AND DISABILITY IN THE ELDERLY) STUDY COHORT A. POGGESI, L. PANTONI, G. PRACUCCI, F. BARKHOF, H. CHABRIAT, T. ERKINJUNTTI, F. FAZEKAS, M. HENNERICI, P. LANGHORNE, J. O'BRIEN, P. SCHELTENS, R. SCHMIDT, A. VERDELHO, M. VISSER, L. WAHLUND, G. WALDEMAR, A. WALLIN, D. INZITARI, ON BEHALF OF THE LADIS STUDY GROUP (Firenze, Amsterdam - NL, Paris - F, Helsinki - FIN, Graz - A, Mannheim - D, Glasgow - UK, Newcastle - upon - Tyne - UK, Lisbon - P, Hud<strong>di</strong>nge - S, Copenhagen - DK, Goteborg - S) 13.15 EPIDEMIOLOGY OF STROKE IN ITALY: A REVIEW S. SACCO, F. STRACCI, D. CERONE, S. RICCI, A. CAROLEI (L’Aquila, Perugia, Città <strong>di</strong> Castello - PG) 13.30 - 14.30 <strong>Pausa</strong> <strong>pranzo</strong> 24 O T T O B R E • S A L A A R C H I M E D E P A D F 23
- Page 1: XLI Congresso Società Italiana di
- Page 7 and 8: Sotto l’Alto Patronato della Pres
- Page 9 and 10: CONSIGLIO DIRETTIVO SIN Presidente
- Page 11 and 12: BREVE STORIA DI CATANIA Seconda cit
- Page 13: AZIENDE ESPOSITRICI 13 Allergan Pha
- Page 16 and 17: SABATO 23 OTTOBRE TEATRO “MASSIMO
- Page 18 and 19: 09.00 11.00 11.30 13.30 13.30 14.30
- Page 20 and 21: 24 O T T O B R E • A U D I T O R
- Page 22 and 23: 24 O T T O B R E • S A L A D E M
- Page 26 and 27: 24 O T T O B R E • S A L A P I T
- Page 28 and 29: 24 O T T O B R E • S A L A F I L
- Page 30 and 31: 24 O T T O B R E • CASI CLINICI:
- Page 32 and 33: 24 O T T O B R E • CONFERENZA DID
- Page 34 and 35: 24 O T T O B R E • CONFERENZA DID
- Page 36 and 37: 24 O T T O B R E • SIMPOSIO ore 1
- Page 38 and 39: 24 O T T O B R E • S A L A A R C
- Page 40 and 41: 24 O T T O B R E • SIMPOSIO ore 1
- Page 42 and 43: 24 O T T O B R E • S A L A SIMPOS
- Page 44 and 45: 24 O T T O B R E • S A L A E M P
- Page 46 and 47: 24 O T T O B R E • S A L A F I L
- Page 48 and 49: 24 O T T O B R E • S A L A A L C
- Page 50 and 51: 24 O T T O B R E • S A L A P A U
- Page 52 and 53: 24 O T T O B R E • S A L A GRUPPO
- Page 54 and 55: LUNEDI 25 OTTOBRE AUDITORIUM SALA E
- Page 56 and 57: 25 O T T O B R E • A U D I T O R
- Page 58 and 59: 25 O T T O B R E • S A L A D E M
- Page 60 and 61: 25 O T T O B R E • S A L A A C R
- Page 62 and 63: 25 O T T O B R E • S A L A A R C
- Page 64 and 65: 25 O T T O B R E • S A L A F I L
- Page 66 and 67: 25 O T T O B R E • CASI CLINICI I
- Page 68 and 69: 25 O T T O B R E • CONFERENZA DID
- Page 70 and 71: 25 O T T O B R E • S A L A CONFER
- Page 72 and 73: 25 O T T O B R E • SIMPOSIO CONGI
- Page 74 and 75:
25 O T T O B R E • SIMPOSIO ore 1
- Page 76 and 77:
25 O T T O B R E • S A L A A L C
- Page 78 and 79:
25 O T T O B R E • SIMPOSIO ore 1
- Page 80 and 81:
25 O T T O B R E • GRUPPO DI STUD
- Page 82 and 83:
25 O T T O B R E • GRUPPO DI STUD
- Page 84 and 85:
25 O T T O B R E • S A L A ASSOCI
- Page 86 and 87:
25 O T T O B R E • S A L A P A U
- Page 88 and 89:
25 O T T O B R E • S A L A ASSOCI
- Page 90 and 91:
09.00 11.00 11.30 13.30 13.30 14.30
- Page 92 and 93:
26 O T T O B R E • A U D I T O R
- Page 94 and 95:
26 O T T O B R E • S A L A D E M
- Page 96 and 97:
26 O T T O B R E • S A L A A C R
- Page 98 and 99:
26 O T T O B R E • S A L A A R C
- Page 100 and 101:
26 O T T O B R E • S A L A P I T
- Page 102 and 103:
26 O T T O B R E • S A L A F I L
- Page 104 and 105:
26 O T T O B R E • CONFERENZA DID
- Page 106 and 107:
26 O T T O B R E • CONFERENZA DID
- Page 108 and 109:
26 O T T O B R E • CONFERENZA DID
- Page 110 and 111:
26 O T T O B R E • SIMPOSIO CONGI
- Page 112 and 113:
26 O T T O B R E • CORSO ore 14.3
- Page 114 and 115:
26 O T T O B R E • S A L A P I T
- Page 116 and 117:
26 O T T O B R E • SIMPOSIO CONGI
- Page 118 and 119:
26 O T T O B R E • A U D I T O R
- Page 120 and 121:
8.30 10.30 11.30 13.30 AUDITORIUM S
- Page 122 and 123:
27 O T T O B R E • S A L A E M P
- Page 124 and 125:
27 O T T O B R E • S A L A F I L
- Page 126 and 127:
27 O T T O B R E • S A L A A L C
- Page 128 and 129:
27 O T T O B R E • S A L A P I T
- Page 130 and 131:
27 O T T O B R E • S A L A F I L
- Page 132 and 133:
27 O T T O B R E • S A L A E M P
- Page 134 and 135:
27 O T T O B R E • S A L A GRUPPO
- Page 136 and 137:
27 O T T O B R E • S A L A A L C
- Page 138 and 139:
27 O T T O B R E • GRUPPO DI STUD
- Page 140 and 141:
27 O T T O B R E • S A L A ASSOCI
- Page 142:
27 O T T O B R E • CHIUSURA DEI L
- Page 145 and 146:
11. BMAA EFFECTS ON SUBSTANTIA NIGR
- Page 147 and 148:
37. MARKERS OF LGG MALIGNANT DEGENE
- Page 149 and 150:
DEMENZA ED INVECCHIAMENTO 1 Moderat
- Page 151 and 152:
OF COMPLETE ATRIOVENTRICULAR BLOCK:
- Page 153 and 154:
110. EVALUATION OF BDNF GENE AS RIS
- Page 155 and 156:
133. THE CLINICAL PICTURE OF PERSIS
- Page 157 and 158:
158. A FAMILY AFFECTED BY PRIMARY F
- Page 159 and 160:
PERFORMANCE: AN IN VIVO FMRI INVEST
- Page 161 and 162:
210. SENSORIMOTOR RHYTHM-BASED BRAI
- Page 163 and 164:
CERAVOLO, S. ROSSI, D. MAFFEI, H. S
- Page 165 and 166:
252. MUTATIONAL ANALYSIS OF THE DCX
- Page 167 and 168:
L. MERICO, M. ACQUAVIVA, A. PANARO,
- Page 169 and 170:
298. DIAGNOSTIC CRITERIA FOR THE DI
- Page 171 and 172:
EPILESSIA 1 Moderatori V. SOFIA (Ca
- Page 173 and 174:
348. FUNCTIONING AND DISABILITY IN
- Page 175 and 176:
MALATTIE DEL MOTONEURONE Moderatori
- Page 177 and 178:
397. FUS GENE ANALYSIS IN AN ITALIA
- Page 179 and 180:
420. INCREASE OF RECENTLY-RELEASED
- Page 181 and 182:
POSTER ore 16.30 - 17.30 DISORDINI
- Page 183 and 184:
459. AMYGDALAR LOCAL STRUCTURAL DIF
- Page 185 and 186:
M. VALERIANI, S. TARANTINO, C. VOLL
- Page 187 and 188:
HEMOGLOBIN SATURATION IN MILD COGNI
- Page 189 and 190:
M. PRONTERA, M. ELIA, G. BOERO, G.
- Page 191 and 192:
F. PESCINI, F. CESARI, B. GIUSTI, J
- Page 193 and 194:
IN STROKE PATIENTS S. VIDALE, C. DE
- Page 195 and 196:
604. EARLY RECOGNITION OF MEMORY IM
- Page 197 and 198:
628. VALUATION OF HEMATOPOIETIC STE
- Page 199 and 200:
652. DIRECT MEDICAL COST OF PATIENT
- Page 201 and 202:
POSTER ore 10.30 - 11.30 DISORDINI
- Page 203 and 204:
NEUROIMMUNOLOGIA Moderatori P. ANNU
- Page 205 and 206:
709. WHITE MATTER ARCHITECTURE AND
- Page 207 and 208:
732. FUNCTIONAL NEUROIMAGING CORREL
- Page 209 and 210:
NEUROSCIENZE DI BASE Moderatori D.
- Page 211 and 212:
785. LAMBERT-EATON MYASTENIC SYNDRO
- Page 213 and 214:
809. BK CHANNEL BETA4 SUBUNIT GENE
- Page 215 and 216:
830. RANDOMIZED PLACEBO-CONTROLLED
- Page 217 and 218:
854. FATIGUE IN MULTIPLE SCLEROSIS
- Page 219 and 220:
878. HEALTH PROFESSIONALS’ PERSPE
- Page 221 and 222:
pagnatori o gli eventuali interessa
- Page 223 and 224:
ECM ● ISTRUZIONI Al Vostro arrivo
- Page 225 and 226:
In particolare, dei 150 crediti del
- Page 227 and 228:
NIHON KOHDEN ITALIA SRL NOVARTIS FA
- Page 229 and 230:
Catania Centro Congressuale Le Cimi
- Page 231 and 232:
Catania Centro Congressuale Le Cimi
- Page 236:
SEGRETERIA ORGANIZZATIVA SIN Studio